AlternativeMed
ancient wisdom Β· Remedy

Shufeng Jiedu Capsule

Shufeng Jiedu Capsule. Chinese patent medicines. For: Used for acute upper respiratory tract infection with wind-heat syndrome, symptoms include fever, nausea, sore throat, headache, nasal congestion, runny nose, cough

πŸ“œ Names
Pinyin Name
Shu Feng Jie Du Jiao Nang
中文名 (Chinese)
η–ι£Žθ§£ζ―’θƒΆε›Š
English Name
Shufeng Jiedu Capsule
πŸ’Š Form & Use
Category
Chinese patent medicines
Dosage Form
θƒΆε›Šε‰‚ (Capsule)
Administration
Oral
Source / 出倄
Chinese Pharmacopoeia 2020 edition
🩺 Syndromes & Indications
Syndromes (δΈ­ζ–‡)
η–ι£ŽζΈ…ηƒ­οΌŒθ§£ζ―’εˆ©ε’½
Indications (δΈ­ζ–‡)
η”¨δΊŽζ€₯ζ€§δΈŠε‘ΌεΈι“ζ„ŸζŸ“ε±žι£Žηƒ­θ―οΌŒη—‡θ§ε‘ηƒ­οΌŒζΆι£ŽοΌŒε’½η—›οΌŒε€΄η—›οΌŒιΌ»ε‘žοΌŒζ΅ζ΅ŠζΆ•οΌŒε’³ε—½
Indications (English)
Used for acute upper respiratory tract infection with wind-heat syndrome, symptoms include fever, nausea, sore throat, headache, nasal congestion, runny nose, cough
0
Clinical Trials
12
Meta-Analyses
3
PubMed References
πŸ“‹ Sample Trials
None linked yet.
πŸ“Š Sample Meta-Analyses
CRD42019149389
The safety of Shufeng Jiedu Capsule in clinical practice: a systematic review and meta-analysis of randomized controlled trials
Shufeng Jiedu Capsule (SFJD) is a common Chinese herbal medicine for many condit
CRD42020185764
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: a protocol for a meta-analysis and systematic review
The conclusion of this study will help us better understand and deal with lung d
CRD42020194320
Shufeng Jiedu capsule for Covid-19 and other respiratory viral infections: a rapid review on current evidence
This rapid review will provide a summary of the current available evidence on SF
CRD42020196234
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): a protocol of a systematic review and meta-analysis
From the end of 2019 to the present, coronavirus disease 2019 (COVID-19) has put
CRD42020205856
Effectiveness of Traditional Chinese Medicine for COVID-19: a systematic review and meta-analysis
The outbreak of the pandemic COVID-19 has continued to spread around the world.
CRD42021224353
Efficacy and safety of Shufeng Jiedu capsule for acute upper respiratory tract infection (URTIs): A Meta-Analysis.
Acute upper respiratory tract infections (URTIs) include tonsillitis, pharyngiti
πŸ“š Sample References
PMID 24647112
Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-ΞΊB pathway
Biosci Trends Β· 2014
PMID 36002086
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-ΞΊB to alleviate LPS-induced ALI
J Ethnopharmacol Β· 2022
PMID 36116201
Shufeng Jiedu capsule ameliorates olfactory dysfunction via the AMPK/mTOR autophagy pathway in a mouse model of allergic rhinitis
Phytomedicine Β· 2022
πŸ₯ Indications β€” click any to find related diseases